Vivek Kanumuri

Vivek Kanumuri practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Vivek Kanumuri's NPI, 1396165312, was assigned on April 17, 2014. Vivek Kanumuri graduated from Rutgers New Jersey Medical School in 2014. Vivek Kanumuri holds Florida license ME163640.

Vivek Kanumuri's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Vivek Kanumuri's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Vivek Kanumuri to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vivek Kanumuri practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Vivek Kanumuri's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Vivek Kanumuri is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Vivek Kanumuri's licenses on file in 2 states: Florida and Massachusetts.

CMS data shows 28 Medicare services from Vivek Kanumuri across 2 procedure codes in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $1,325 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 45 Medicare patients who saw Vivek Kanumuri in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Vivek Kanumuri's median patient age at 68, with 42% women.

In 2024, Vivek Kanumuri wrote 18 Medicare Part D claims for 13 patients. 100% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $32 in total drug cost. In 2019, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Vivek Kanumuri for performance year 2024, reported as part of a group. Vivek Kanumuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Vivek Kanumuri as offering telehealth.

Dmand AI links 39 papers to Vivek Kanumuri, published from 2012 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Tomography, X-Ray Computed, Endoscopy and Auditory Brain Stem Implants. Vivek Kanumuri has published most often in Otolaryngol Head Neck Surg. Vivek Kanumuri's most frequent co-authors are Elliott D. Kozin, MD, Jean Anderson A. Eloy, MD and Daniel J. Lee, MD.

CMS Open Payments shows 19 general payments to Vivek Kanumuri from 5 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 56% of the total. Cochlear Ltd paid the most, $967.

Vivek Kanumuri graduated from Rutgers New Jersey Medical School in 2014.

Vivek Kanumuri is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.